Dr. Lal PathLabs Ltd (NSE:LALPATHLAB)
₹ 3053.05 52.65 (1.75%) Market Cap: 254.35 Bil Enterprise Value: 245.06 Bil PE Ratio: 62.28 PB Ratio: 12.49 GF Score: 100/100

Dr. Lal PathLabs Ltd to Discuss Business Updates Call Transcript

Mar 30, 2020 / 12:30PM GMT
Release Date Price: ₹1424.75 (-5.14%)
Operator

Ladies and gentleman, good day and welcome to the Dr. Lal PathLabs Conference Call to discuss business updates. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Nishid Solanki from CDR India. Thank you, and over to you.

Nishid Solanki
CDR India - IR Manager

Thank you. Good evening, everyone, and welcome to today's call hosted by Dr. Lal PathLabs to share business updates and discuss the situation arising out of COVID-19, the company's empanelment for testing for COVID-19 and overall sentiments in the diagnostic industry. Joining us today are senior members of the management team including Honorary Brigadier, Dr. Arvind Lal, Chairman and Managing Director; Dr. Om Prakash Manchanda, Whole Time Director and CEO; and Mr. Ved Prakash Goel, CFO. We also have with us, Mr. Bharath, CEO, India Business; and Mr. Rajat Kalra, Company Secretary and Head of Investor Relations.

Before we announce the call -- before we commence the call, I would like to underline that some of the statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot